Numinus Announces Departure of Stacey Wallin Post published:November 25, 2021 Post category:Press Release
Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note Post published:November 24, 2021 Post category:Press Release
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus Post published:November 24, 2021 Post category:Press Release
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs Post published:November 24, 2021 Post category:Press Release
COMPASS Pathways granted fifth US patent for crystalline psilocybin Post published:November 23, 2021 Post category:Press Release
Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities Post published:November 23, 2021 Post category:Press Release
Numinus to Host Q4 and 2021 Annual Results Conference Call on December 9, 2021 Post published:November 22, 2021 Post category:Press Release
HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada Post published:November 22, 2021 Post category:Press Release
PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications Post published:November 19, 2021 Post category:Press Release
Psychedelic Bulletin: DEA Again Increases Psychedelics Production Quotas; MindMed Announces Microdosing Study; Shorter Trips? Post published:November 19, 2021 Post category:Psychedelic Bulletin